Dietary Fatty Acids
What Fatty Acids Are Present in the Diet?
As shown in Figure 1 , fatty acids consist of a straight chain of carbon atoms with a carboxylic end (COOH) and a methyl (CH 3 ) or omega end and are classified based on the saturation of the carbon chain. Common saturated fatty acids, those with no double bonds, include palmitic acid (16:0) and stearic acid (18:0) . Foods high in saturated fatty acids include dairy products, red meats, and tropical oils. 2 Unsaturated fatty acids are further classified based on the number and location of double bonds. Monounsaturated fatty acids, such as oleic acid (18:1n9) , have a single double bond, whereas polyunsaturated fatty acids (PUFA) have multiple double bonds. 6 PUFA, such as linoleic acid (LA, 18:2n6) and arachidonic acid (AA, 20:4n6), have the first double bond located at the sixth carbon (when counting from the omega end) and are found readily in dietary sources such as vegetable oils, meat, eggs, and dairy. 3 PUFA, such as ␣-linolenic acid (ALA, 18:3n3), eicosapentaenoic acid (EPA, 20:5n3), and docosahexaenoic acid (DHA, 22:6n3), have the first double bond located at the third carbon. Although ALA is found in flax seed and other plants, EPA and DHA are primarily found in fatty fish, such as salmon. 2 
How Are Dietary Fatty Acids Used and Stored by the Body?
Dietary fatty acids are metabolized as fuel for oxidative phosphorylation, stored as triglycerides, or rapidly incorporated into plasma phospholipids, high-density lipoprotein particles, and cell membranes. Fatty acids seldom exist in a "free" form; nonesterified fatty acids are bound by plasma albumin. The mass of lipids incorporated into the various lipid pools limits the kinetics of turnover. Plasma triglyceride composition can be modified within days of a dietary modification, but changes in cardiac tissue lipid composition resulting from dietary changes require several weeks to reach steady state. In patients scheduled for cardiac surgery (with low dietary fish intake), a 1-month treatment with fish oil (2.9% energy as EPA and DHA, 3 g/d) raised the content of those lipids in the right atrial appendage (removed at surgery) from 5.3% to 11.5%, and decreased the AA content from 21% to 16%. 3 Interestingly, dietary supplementation with energy equivalent quantities of ALA or olive oil had no significant impact on cardiac lipid composition. 3 Experimental studies also show that diets enriched with long-chain 3 PUFA lead to 3 PUFA incorporation into cardiac tissues. 4, 5 
Epidemiological Data Show That Dietary Fatty Acids Affect Cardiovascular Health
Epidemiological studies suggest that the composition of dietary fatty acids (eg, saturated versus unsaturated; 3 versus 6, etc) has important consequences for cardiovascular health and cardiac arrhythmogenesis. 6 Saturated and trans-fats increase cardiovascular risk. 6 Both 3 and 6 PUFA have shown some evidence of cardiovascular benefit. 7, 8 Regional and ethnic differences in food availability and preference result in significant variations in dietary fatty acid composition. Hibbeln et al 8 reported an inverse relationship between dietary 3 PUFA intake and mortality resulting from cardiovascular disease, with the lowest mortality reported in countries such as Japan, Greenland, and Iceland, whose citizens have the highest proportion dietary lipid calories derived from 3 PUFA. Interestingly, the proportion of dietary calories derived from fat was high in Greenland and relatively low in Japan, yet both countries showed decreased cardiovascular risk. Although dietary ALA is more readily available (from plant-based sources), evidence is stronger for a cardiovascular benefit of EPA and DHA than for ALA. 9 Among the 6 PUFA, a recent AHA advisory cites several epidemiological and prospective cohort studies showing that individuals with the highest tissue/blood levels of LA had the lowest cardiovascular risk. 7 
AHA Guidelines for Dietary Fats
The American Heart Association (AHA) recognizes that dietary fatty acids and cardiovascular disease risk are interrelated. Current AHA Dietary Guidelines recommend limiting total fat intake to Ͻ35% of daily calories, with saturated fat Ͻ7% of daily calories, and the remainder coming from monounsaturated and polyunsaturated fats. 2 It is intriguing, however, that the Women's Health Initiative reported that a low-fat diet did not significantly affect cardiovascular disease incidence and only modestly altered the risk factors for cardiovascular disease. 10 
Stress-Dependent Effects of Dietary Fats
The impact of dietary fatty acids on cardiovascular function under normal conditions may differ from that under conditions of hemodynamic, ischemic, or autonomic stress. Under normal conditions, fatty acids are used for many cellular processes; however, when lipid availability exceeds the capacity for utilization, fatty acids can alter mitochondrial structure 11 and function, increasing lipid peroxidation, 12 mitochondrial uncoupling, and reactive oxygen species production, 13 eventually leading to cytochrome c release, caspase activation, DNA laddering, and apoptosis. 14, 15 Despite evidence showing that dietary fat can be cytotoxic, dietary fat appears cardioprotective in several animal models of left ventricular dysfunction. Studies in the Dahl salt-sensitive rat model of hypertension-induced cardiomyopathy, 16 a mouse model of transverse aortic constriction, 17 and a rat model of abdominal aortic banding 18 have shown that 60% high saturated fat feeding did not exacerbate the hypertrophic response to injury. A 60% high saturated fat diet in a rat model of coronary artery ligation-induced heart failure also did not adversely affect myocardial contractile function but increased mitochondrial enzyme activities and oxidative phosphorylation. 19, 20 These alterations in mitochondrial function were not evident in sham animals fed high saturated fat, 19 suggesting that the effects of a high fat diet represented responses to pathological stress. In a subsequent study, mitochondrial oxidative phosphorylation was unaltered in rats fed a high fat diet after ligation surgery but was decreased in sham animals fed the high fat diet. 21 However, the proarrhythmic consequences of such a diet are notable; rats fed the same high fat diet before coronary artery ligation had an increased risk of sudden death early after myocardial infarction. 20 These studies suggest that manipulation of dietary fat content and composition can have different effects under normal versus pathological conditions and that ischemic and hemodynamic stressors can modify the outcome.
Arrhythmogenic Mechanisms Affected by Dietary Fatty Acids
Dietary fatty acids can promote and/or prevent cardiac arrhythmia via several pathways (Figure 2 ), including (1) modulation of electrophysiological and metabolic heterogeneities secondary to atherosclerotic disease, (2) modulation of cardiac myocyte metabolic activity and cardiovascular oxidant stress, (3) direct modulation of ion channel and transporter activity, (4) indirect modulation of ion channel and transporter activity, via modulation of autonomic nervous system activity, and (5) modulation of inflammatory pathways that promote ectopic electric activity and abnormal conduction. These mechanisms are considered in the paragraphs below.
1: Dietary Fatty Acids, Atherosclerosis, and Arrhythmogenesis
Elevated blood cholesterol and triglycerides are associated with increased risk for cardiovascular disease. 1 Although dietary saturated fat increases cardiovascular risk, 6 3 PUFA have been shown to decrease plasma triglyceride content 16, 22, 23 and cardiovascular risk. One potential antiarrhythmic mechanism involves modulation of the extent of atherosclerosis and subsequent cardiac ischemia. The impact of dietary fatty acid composition on the development of atherosclerosis was recently evaluated in 3 different populations: Japanese men living in Japan, American men, and men of Japanese origin living in the United States. 24 The Japanese men living in Japan consumed a diet more enriched in 3 PUFA than the American diet and had less atherosclerosis, with a significant inverse relationship between serum 3 PUFA levels and carotid intima-medial thickness. 24 Japanese men living in the United States had more atherosclerosis than either the native Japanese or American men, suggesting that genetic factors do not underlie this relationship. 24 This and other studies suggest that consumption of a diet enriched in 3 PUFA is antiatherogenic. The GISSI Prevenzione trial reported that consumption of a Mediterranean diet supplemented with 1 g per day of 3 PUFA (but not vitamin E) was associated with a 45% reduction in the incidence of sudden cardiac death. 25 Animal studies also have shown that dietary manipulation of lipid composition profoundly affects cardiac arrhythmogenesis. Pepe et al 26 reported that animals fed a diet enriched with saturated fat had increased susceptibility to ventricular fibrillation and tachycardia after ischemia and reperfusion; fish oil supplementation reversed these effects. Although atherosclerosis-induced ischemia is an important element of arrhythmogenesis, it is not the only factor affected by dietary fatty acids.
2: Impact of Dietary Lipids on Cardiac Metabolism and Arrhythmogenesis
Arrhythmias frequently occur in the metabolically challenged heart, consistent with the hypothesis that metabolic instability underlies electric instability. 27 Possible mediators include insufficient ATP for contractile and ion cycling requirements, lack of oxygen, lack of substrate availability, or impaired enzymatic activity. 27 Fatty acids are the primary energy substrate in the healthy heart. With the development and progression of ventricular dysfunction, expression of the primary transcriptional regulator of fatty acid metabolism in the heart, peroxisome proliferator activated receptor-␣ (PPAR␣), and enzymes involved in fatty acid oxidation are downregulated. 28 -30 Studies in human 31 and animal heart failure models have reported abnormalities in mitochondrial morphology, 32 damage to the phosphorylation apparatus, and decreased mitochondrial respiration [33] [34] [35] and electron transport chain activities. 36, 37 Atrial tissues from patients with AF show evidence of abnormal mitochondrial morphology, 38 deletion of mitochondrial DNA segments, 39 decreased oxidative phosphorylation, 38 and increased proton leak. 40 Changes in atrial mitochondrial structure similar to those that occur in heart failure seem likely to contribute to the progression of AF; however, alterations in atrial energetics during the progression of AF are currently less well characterized than in the failing ventricle.
Although the role of metabolic alterations in arrhythmogenesis is not well understood, there is a clear association between dietary lipids and metabolism. Specific actions of fatty acids can vary, depending on the composition of the fatty acid (saturation, chain length, etc). For example, fatty acids are natural ligands for PPAR␣, but long-chain unsaturated fatty acids are more effective ligands than long-chain saturated and short-chain fatty acids. 41, 42 Dietary PUFAs lower plasma 16, 22, 23 and tissue triglycerides 43 ; however, dietary 3 PUFAs (EPA, DHA, and ALA) decrease serum triglycerides and phospholipids more effectively than LA (an 6 PUFA). 43 Supplementation of an ALA-enriched diet with EPA/DHA has been reported to further increase the expression of genes involved in mitochondrial biogenesis and fatty acid oxidation. 44 It seems plausible that diets enriched in protective fatty acids (eg, LA, ALA, EPA, and DHA) could decrease metabolic stress and reduce the incidence of metabolically induced arrhythmias.
Oxidant Stress in Heart Failure and Arrhythmia
Failing hearts frequently show signs of oxidant stress, 45, 46 including lipid peroxidation, protein nitration, and other post-translational modifications induced by the interaction of reactive oxygen and nitrogen species with cellular proteins and lipids. Our group was the first to show evidence of oxidative stress in the atria of patients with AF, 47 with increased nitrotyrosine abundance (a marker of peroxynitrite formation) in atria from AF patients. Others have shown that the redox state is more oxidized and that markers of oxidant stress are elevated in the plasma of patients with AF. 48 Mitochondria are a major source of oxidant generation and an important target for oxidative damage. Cardiolipin, a phospholipid unique to the mitochondrial inner membrane, is susceptible to oxidative modification because of its highly unsaturated structure and its proximity to the electron transport chain. 49 Because cardiolipin plays an essential role in the structure and activity of electron transport chain complexes, alterations in cardiolipin content have serious implications for mitochondrial energy production. The resulting inhibition of the electron transport chain can promote generation of reactive oxygen species at complexes I 36 and III. 37 Oxidant Figure 2 . Pathways underlying lipid modulation of cardiac arrhythmogenesis. Lipids can promote cell injury and inflammation, which can increase lysophospholipids (lysoPL) through enhanced phospholipase A 2 (PLA 2 ) activity. Dyslipidemia also leads to loss of vagal tone and sympathetic dominance, resulting in decreased heart rate variability and increased heart rate. These effects promote myocyte calcium overload, which amplifies cellular injury. Calcium overload also promotes oxidative stress and inhibition of mitochondrial oxidative phosphorylation.
production also can result in modification of mitochondrial proteins. Reactive nitrogen species inhibit the activity of mitochondrial enzymes aconitase, catalase, and glutathione peroxidase, as well as various components of the electron transport chain. 50 Oxidant stress is increased in patients after cardiac surgery. In a small, case-controlled study, serum total peroxide levels and right atrial protein oxidation at 6 hours after cardiac surgery were greater in patients who later had postoperative AF than in those who did not. 51 A proteomic analysis of atrial tissues from surgical patients reported that patients who had postoperative AF also showed evidence of metabolic alterations and depletion of the antioxidant protein peroxiredoxin. 52 Preservation of cardiac mitochondrial function, therefore, could be an important step toward preventing disease progression.
Mitochondrial oxidant generation is sensitive to dietary lipid composition. Experimentally, a cholesterol-rich diet promoted increased superoxide production, nitrotyrosine abundance, and cardiac dysfunction 53 ; however, expression of cardiac antioxidants Mn-superoxide dismutase and glutathione peroxidase was enhanced in rats fed an 3 PUFAenriched (EPA and DHA) diet compared with those fed a saturated fat diet. 54 Additionally, 3 PUFA supplementation of a diet rich in saturated fats increased the efficiency of oxygen utilization and inhibited arrhythmias associated with ischemia and reperfusion. 26 Together, these studies provide evidence that dietary 3 PUFA enrichment may attenuate arrhythmia risk, in part by preserving mitochondrial function.
3: Modulation of Ion Channel and Transporter Activity
Intracellular sodium and calcium homeostasis is a critical determinant of arrhythmogenesis, and levels of these ions are coregulated by the activity of the sodium-calcium exchanger (NCX). NCX normally provides a brief period of calcium influx during the peak of the action potential and facilitates calcium extrusion during the action potential plateau. Increased intracellular sodium levels resulting from rapid heart rate or altered sodium channel inactivation impede NCXmediated calcium extrusion. Although elevated cytosolic calcium can have a positive inotropic effect, calcium overload has metabolic, 55 arrhythmogenic, 56, 57 and contractile 58 consequences. In patients with AF, atrial NCX protein expression was increased by 67% relative to control patients with no history of AF. 59 NCX current is sensitive to the lipid composition of the membrane and to plasma lipids. In porcine ventricular myocytes, dietary fish oil supplementation prevented calcium overload and reduced the incidence of triggered activity in response to norepinephrine exposure. 60 Fatty acid block of NCX is isoform specific; whereas NCX1.1 is only blocked by 3 PUFAs (EPA, DHA), multiple fatty acids can inhibit NCX1.3 currents. 61 Modulation of calcium influx is an important element underlying the beneficial effects of 3 PUFAs on cardiac electric activity.
Exposure of myocytes to oxidant stress is reported to increase reverse-mode NCX activity 58 and protein expression, 62 to delay the inactivation of the sodium current, 63 and to modulate NCX current, 64 in part secondary to the increased sodium load resulting from oxidant modified sodium channels. 63 Delayed sodium channel inactivation, often referred to as "late" sodium current, has been documented in myocytes from failing hearts 65 and in human atrial myocytes. 66 Sodium entry via late sodium current can prolong the action potential plateau, resulting in increased intracellular sodium load, increasing risk of early afterdepolarizations and triggered and ectopic electric activity. 67 Fish oil-derived 3 PUFAs (EPA and DHA) suppress late sodium current in cells expressing recombinant human cardiac sodium channels. 68 In the setting of ischemia, lipid metabolism is a critical modulator of cardiac electric activity. Under ischemic conditions, phospholipase A 2 is activated, promoting the release of fatty acids such as AA (6 PUFA) and lysophospholipids from the cell membrane. In regional ischemia, AA and lysophospholipid release contribute to the development of proarrhythmic heterogeneities of conduction velocity and repolarization. AA can uncouple gap junctions, 69 leading to conduction slowing, and modify the activity of voltagedependent sodium, calcium, and potassium channels. AA metabolites can modify cardiac ion channel activity (isoketals 70 ) and activate G-protein-coupled receptors (EP, FP 71 ) that promote ectopic electric activity. Lysophospholipids also modulate ion channel and mitochondrial activity. 72, 73 The quantity of AA released during ischemia is dependent on its abundance in the cell membrane, which is sensitive to dietary fatty acid composition. In a canine acute infarction model, pretreatment with a diet enriched with 3 PUFA attenuated the arrhythmogenic response to ischemia. 74 Similarly, patients who had ventricular fibrillation during a first myocardial infarction were reported to have lower levels of 3 incorporated into cell membranes than those who did not. 75 Thus, the type of dietary fatty acids incorporated into cardiac membranes is an important determinant of the electrophysiological response of the heart to ischemia.
Antiarrhythmic Effects of Infusion/Superfusion Versus Dietary Incorporation of Fatty Acids
To probe the therapeutic benefit of modifying lipid composition on cardiac electric activity, several studies have evaluated the effects of acute infusion of lipid emulsions on experimentally induced arrhythmias. In a canine model of ischemia during exercise after myocardial infarction, Billman et al 76 showed that infusion of an 3 PUFA-enriched emulsion protected animals from sudden death caused by lethal ventricular fibrillation. Emulsions containing individual 3 PUFAs (EPA, DHA, or ALA) were similarly protective. 77 Antiarrhythmic efficacy was associated with a slower heart rate, shorter Q-T interval (corresponding to effects on ventricular action potential duration), reduced left ventricular systolic pressure, and prolonged atrial-ventricular conduction time (P-R interval of the ECG). 76 In normal dogs given an acute infusion of either 3 PUFA or 6 PUFA, neither PUFA affected atrial effective refractory period (aERP), R-R interval, P-wave duration, P-Q interval, QRS duration, QT or QT c interval over a 6-hour period. 78 However, after 6 hours of rapid atrial pacing, infusion with the 3 PUFA but not the 6 PUFA attenuated the characteristic pacing-induced abbreviation of aERP. 75, 78 Lipid infusion/superfusion may not accurately predict the cellular response to dietary fatty acids. In cultured neonatal cardiac myocytes, acute superfusion with DHA (3) but not AA (6) also slowed spontaneous beating rate, decreased calcium influx via L-type calcium channels, and attenuated the response of the calcium channel to the dihydropyridine agonist Bay K 8644. 79 Dietary changes in 3 PUFA consumption have a more subtle electrophysiological impact than the acute effects of lipid infusion or superfusion. Whereas superfusion of isolated myocytes with 3 PUFAs (EPA) acutely suppressed sodium current, 80 electrophysiological studies of ventricular myocytes isolated from pigs administered an 3 PUFA-enriched diet for 8 weeks showed no evidence of altered sodium current density or voltagedependent channel activation. 81 Nonetheless, dietary administration of 3 PUFA is associated with alterations in ion channel/exchanger activity. Consistent with the acute superfusion studies, a hyperpolarizing shift in sodium channel steady-state inactivation was observed in pigs fed an 3 PUFA-enriched diet. 81 Ventricular myocytes from these animals had attenuated NCX currents, an abbreviated action potential duration, and an Ϸ20% reduction in peak L-type calcium current density, with no change in voltage-dependent activation or inactivation parameters. 81 Diastolic calcium levels and calcium transient amplitude were not altered in animals receiving the 3 PUFA-enriched diet, but decay of the calcium transient was accelerated. 81 Inward rectifier K ϩ current (I K1 ) and slow delayed rectifier K ϩ current (I Ks ) densities were increased. 81 Overall, this study suggests that dietary 3 PUFA supplementation shortens ventricular action potential duration, simultaneously decreasing the occurrence of early afterdepolarizations and triggered arrhythmic activity via altered action potential duration and changes in cytosolic calcium handling.
4: Autonomic Modulation of Ion Channel and Transporter Activity
Heart rate is controlled by parasympathetic (vagal) and sympathetic (␤-adrenergic) nerves innervating the sinoatrial and atrioventricular nodes. Excessive stimulation of either parasympathetic or sympathetic nerves promotes arrhythmogenic responses, 82 due either to atrial action potential shortening (strong vagal stimulation) or excessive calcium influx (calcium channel phosphorylation due to adrenergic phosphorylation). In the (small) subset of young, athletic individuals with AF, increased vagal tone and slow heart rate may contribute to the onset of AF.
In the majority of individuals with senile AF, the patients have elements of the metabolic syndrome (obesity, dyslipidemia, insulin resistance, hypertension). Vagal withdrawal occurs in patients with metabolic syndrome and heart failure, leading to sympathetic dominance, abnormal heart rate variability, 83, 84 and elevated resting heart rate 85 (Figure 2) . Although sympathetic stimulation can provide for acute increases in calcium influx, contractility, and energy production, persistent sympathetic activation promotes ectopic electric activity and initiation of the apoptotic cascade. 86 Interventions that improve vagal tone, including exercise and dietary 3 PUFA supplementation, favorably affect mechanisms of cardiac arrhythmogenesis, potentially due to vagal modulation of heart rate and calcium cycling. 87 Vagal activity also has anti-inflammatory effects, protecting the heart from the deleterious effects of excessive cytokine stimulation. 88 Several clinical studies have reported decreased heart rate after increased dietary fish intake 89 and administration of fish oil capsules. 90 -92 A modest improvement in heart rate variability was reported in individuals with high fish consumption, 93 consistent with improved vagal tone. However, in a small study of patients after myocardial infarction, 1g/d 3 PUFAs did not affect heart rate variability. 94 Similarly, a study by Geelen et al 95 reported no change in heart rate variability or baroreceptor sensitivity in healthy subjects after fish oil supplementation. Factors influencing the response of heart rate and heart rate variability to dietary 3 PUFAs may include (1) the baseline plasma and tissue lipid composition, (2) the baseline systemic inflammatory and autonomic state, (3) the dose and duration of 3 PUFA supplementation, and (4) the specific composition of 3 PUFAs in the diet (as ALA, EPA, and DHA have distinct effects 5, 90 ).
5: Modulation of Inflammatory Pathways That Lead to Changes in Cardiac Conduction
Eicosanoids have physiological and pathological effects on the heart, affecting both heart rate and the structural responses to hemodynamic stress. 96 Dietary fatty acids can affect cardiovascular function by modulating systemic inflammatory pathways. Activation of leukocytes (especially monocytes and macrophages) promotes the release of AA, which is then metabolized into chemotactic compounds (eg, leukotriene B 4 , LTB 4 ) that recruit inflammatory cells (neutrophils, monocytes) to injured tissues. The corresponding 3 PUFA metabolite LTB 5 is much less effective as a chemokine. 97 Slow and heterogeneous conduction is prominent in areas with increased inflammatory cell infiltration 98 ; however, the cellular basis for inflammatory arrhythmias is not well defined. 99 In studies based on receptor knockout mice, thromboxane A 2 and prostaglandin F 2␣ (both AA metabolites) were implicated as mediators of inflammatory tachycardias. 100 Increased 3 PUFA consumption decreases the availability of AA and subsequently may modulate the production of prostaglandin E 2 and other inflammatory eicosanoids. 101, 102 Duda et al 102 reported that serum levels of tumor necrosis factor-␣ (TNF-␣), as well as urinary thromboxane B 2 and 6-keto prostaglandin F 1 , were elevated in a rat model of abdominal aortic banding. Dietary EPA/ DHA supplementation blunted this effect and attenuated the left ventricular remodeling and systolic dysfunction that is characteristic of the abdominal aortic banding model. 102 Cardiac-specific deletion of cyclooxygenase-2 (COX-2) expression eliminates the ability to synthesize COX-2-dependent eicosanoids; these mice have a slower heart rate and increased fibrosis after aortic banding. 96 Together, these studies suggest that eicosanoids are important modulators of cardiac function and arrhythmogenesis. The balance of dietary 3 and 6 PUFAs modulates the distribution of eicosanoids produced, thus affecting heart rate, ectopic activity, and cardiac conduction patterns.
Impact of Dietary Fatty Acids on Cardiac Fibroblasts and Interstitial Fibrosis
Arrhythmias require an initiating trigger and a substrate to become persistent. Structural remodeling, including reactive and replacement fibrosis, often underlies reentrant arrhythmias. Fibroblast expression is normally low in the healthy heart but increases in response to inflammatory stimuli and with advanced age, hypertension, hemodynamic overload, valve dysfunction, and heart failure. 103 Multiple signaling pathways regulate the development of interstitial fibrosis, with prominent roles evident for the renin-angiotensin system, 104 aldosterone, 105 and cytokines, including plateletderived growth factor (PDGF), 106 transforming growth factor-␤ (TGF-␤), 107 TNF-␣, 108 and AA metabolites. 109 Fish oil (3 PUFA) has been shown to suppress endothelial PDGF formation. 110 As fibrosis is an important determinant of arrhythmia persistence, it is not surprising that antifibrotic agents demonstrate antiarrhythmic efficacy (eg, angiotensinconverting enzyme inhibitors, 104 statins, 111 and aldosterone antagonists 105, 112 ).
Fibroblast proliferation and extracellular matrix accumulation is a normal and important element of wound healing. 113 In conditions such as heart failure and myocardial infarction, fibroblasts elaborate extracellular matrix components (primarily collagen) that can provide stiffness to injured myocardium. In heart failure, fibroblast proliferation and matrix accumulation occur more rapidly in the atrial than ventricular myocardium, contributing to an increase in AF vulnerability. 114 Myocyte interactions with myofibroblasts can promote heterogeneous conduction, 115, 116 because myofibroblasts typically have a less negative (more depolarized) resting potential than cardiac myocytes. Miragoli et al 116 showed that myofibroblasts can modulate conduction velocity and ectopic activity 115 of cardiac tissues, primarily via gap junctionmediated electrotonic interactions. In a canine model of heart failure subsequent to rapid ventricular pacing, development of atrial interstitial fibrosis has also been shown to be a critical determinant of AF episode duration. 117 In this model, aERP was prolonged, and, after the development of atrial fibrosis, arrhythmia episode duration became independent of the electric remodeling status. 118 
Fibrosis, Dietary Lipids, and Arrhythmogenesis
Dietary lipids are implicated in the development of cardiac fibrosis and modulate arrhythmias that are fibrosisdependent. Aubin et al 119 reported that rats fed a high-fat diet (42% by calories versus 12.5% in control rats) for 8 weeks became hypertensive and had evidence of reactive fibrosis; unfortunately, the composition of dietary lipids was not reported. 119 In a comparison of 2 AF models, Sakabe et al 120 reported that oral administration of 3 PUFA (EPA/DHA) suppressed AF inducibility and duration in a canine model of ventricular pacing-induced heart failure; in contrast, it did not modify aERP changes resulting from 1 week of rapid atrial pacing. This result contrasts with the effects of 3 PUFA infusion on acute aERP changes after rapid atrial pacing. 78 In the same canine ventricular pacing-induced heart failure model, dietary supplementation with 3 PUFAs attenuated the development of atrial fibrosis 121 and prevented vagally induced AF. 121 A recent clinical trial suggests that supplemental 3 PUFA therapy can help to prevent perioperative AF. 122 After coronary artery bypass graft surgery, 15% of patients randomly assigned to receive the 3 PUFA supplement had AF, compared with 33% of the control patients. 122 Patients who received 3 PUFAs also had a shorter length of hospital stay. 122 Because of the promising preclinical and clinical evidence, several randomized trials of supplemental 3 PUFA for prevention of postoperative AF or recurrent AF are underway, seeking to confirm and extend the encouraging preclinical and clinical observations.
Summary and Conclusions
The specific composition of dietary lipids, the daily caloric intake, and the fraction of calories consumed as lipids are quite variable around the world. Epidemiological data suggest that the typical Western diet is not optimal from the perspective of cardiovascular health or longevity. The Western diet is frequently excessive with respect to total calories consumed, calories derived from sugar, and calories derived from saturated or trans-fatty acids. In contrast, the Western diet is often deficient with respect to 3 PUFA content. The prevalence of cardiovascular disease and death caused by arrhythmia is increased in the United States, relative to populations consuming Mediterranean diets or those regions with greater 3 PUFA content.
Dietary lipids can promote the development of atherosclerosis 1, 6 and activation of inflammatory cells. 100 In the setting of ischemia, fatty acid metabolites can exacerbate vasoconstriction, spontaneous electric activity, and heterogeneities of repolarization and conduction (by modulating voltage-gated ion channels, gap junctions, intracellular calcium homeostasis, and ectopic electric activity). 69 -73 These alterations promote arrhythmogenesis. However, dietary fatty acids also can have numerous beneficial effects (Figure 3 ). 3 PUFAs Figure 3 . Antiarrhythmic effects of dietary 3 PUFA. 3 PUFAs decrease fibrosis by inhibiting cytokine production and systemic inflammation (PDGF, platelet-derived growth factor; CRP, C-reactive protein; TNF-␣, tumor necrosis factor-␣; and IL-6, interleukin-6). Inhibition of cytokine production and antioxidant effects minimize reactive oxygen (ROS) and reactive nitrogen (RNS) production, resulting in decreased post-translational modification of ion channels and preservation of a reduced redox state. Decreased ROS production improves ATP production by oxidative phosphorylation, limiting sodium loading, calcium overload, and ectopic activity. Finally, 3 PUFA can prevent apoptosis induced by mitochondrial calcium overload decrease the inflammatory response to injury 101, 102 and the development of fibrosis in the setting of heart failure. 120, 121 In addition, 3 PUFAs may preserve mitochondrial function by decreasing oxidant stress and subsequent inhibition of the electron transport chain. In the setting of inflammation or failure, vagal tone is preserved or enhanced, and heart rate is slowed. These effects of 3 PUFA are anticipated to promote the maintenance of normal cardiac rhythm.
Diet affects autonomic tone. In young athletic individuals with AF, increased vagal tone may contribute to the etiology of AF; in such individuals, increased dietary 3 fatty acid intake might not be advisable. In contrast, for individuals with elements of the metabolic syndrome, changes in dietary lipid composition may lower the risk of cardiovascular disease and cardiac arrhythmia. Preventative measures, including changes such as increased 3 PUFA consumption, in combination with lifestyle changes (increased activity) may help to achieve this goal. Development of practical and effective guidelines will require additional research to determine the nature and extent of changes required and to identify optimal dietary sources of 3 PUFA.
